Literature DB >> 24014027

p87 and p101 subunits are distinct regulators determining class IB phosphoinositide 3-kinase (PI3K) specificity.

Aliaksei Shymanets1, Kirsten Bucher, Sandra Beer-Hammer, Christian Harteneck, Bernd Nürnberg.   

Abstract

Class IB phosphoinositide 3-kinase γ (PI3Kγ) comprises a single catalytic p110γ subunit, which binds to two non-catalytic subunits, p87 or p101, and controls a plethora of fundamental cellular responses. The non-catalytic subunits are assumed to be redundant adaptors for Gβγ enabling G-protein-coupled receptor-mediated regulation of PI3Kγ. Growing experimental data provide contradictory evidence. To elucidate the roles of the non-catalytic subunits in determining the specificity of PI3Kγ, we tested the impact of p87 and p101 in heterodimeric p87-p110γ and p101-p110γ complexes on the modulation of PI3Kγ activity in vitro and in living cells. RT-PCR, biochemical, and imaging data provide four lines of evidence: (i) specific expression patterns of p87 and p101, (ii) up-regulation of p101, providing the basis to consider p87 as a protein forming a constitutively and p101 as a protein forming an inducibly expressed PI3Kγ, (iii) differences in basal and stimulated enzymatic activities, and (iv) differences in complex stability, all indicating apparent diversity within class IB PI3Kγ. In conclusion, expression and activities of PI3Kγ are modified differently by p87 and p101 in vitro and in living cells, arguing for specific regulatory roles of the non-catalytic subunits in the differentiation of PI3Kγ signaling pathways.

Entities:  

Keywords:  G-proteins; Gβγ p101; Phosphatidylinositol 3-Kinase; Phosphatidylinositol Signaling; Phosphoinositide 3-Kinase γ (PI3Kγ); Phospholipid; Signal Transduction; p87

Mesh:

Substances:

Year:  2013        PMID: 24014027      PMCID: PMC3829419          DOI: 10.1074/jbc.M113.508234

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion.

Authors:  Sze Ki Luk; Roland P Piekorz; Bernd Nürnberg; Shing-Shun Tony To
Journal:  Eur J Cancer       Date:  2011-11-11       Impact factor: 9.162

Review 2.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Gbeta 5gamma 2 is a highly selective activator of phospholipid-dependent enzymes.

Authors:  U Maier; A Babich; N Macrez; D Leopoldt; P Gierschik; D Illenberger; B Nurnberg
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

5.  Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis.

Authors:  J A Brazzatti; M Klingler-Hoffmann; S Haylock-Jacobs; Y Harata-Lee; M Niu; M D Higgins; M Kochetkova; P Hoffmann; S R McColl
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

6.  P110delta, a novel phosphoinositide 3-kinase in leukocytes.

Authors:  B Vanhaesebroeck; M J Welham; K Kotani; R Stein; P H Warne; M J Zvelebil; K Higashi; S Volinia; J Downward; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.

Authors:  B Stoyanov; S Volinia; T Hanck; I Rubio; M Loubtchenkov; D Malek; S Stoyanova; B Vanhaesebroeck; R Dhand; B Nürnberg
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

8.  PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.

Authors:  Enrico Patrucco; Antonella Notte; Laura Barberis; Giulio Selvetella; Angelo Maffei; Mara Brancaccio; Stefano Marengo; Giovanni Russo; Ornella Azzolino; Sergei D Rybalkin; Lorenzo Silengo; Fiorella Altruda; Reinhard Wetzker; Matthias P Wymann; Giuseppe Lembo; Emilio Hirsch
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

9.  PI3K signalling: the path to discovery and understanding.

Authors:  Bart Vanhaesebroeck; Len Stephens; Phillip Hawkins
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-23       Impact factor: 94.444

Review 10.  Structural basis for activation and inhibition of class I phosphoinositide 3-kinases.

Authors:  Oscar Vadas; John E Burke; Xuxiao Zhang; Alex Berndt; Roger L Williams
Journal:  Sci Signal       Date:  2011-10-18       Impact factor: 8.192

View more
  14 in total

1.  p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration.

Authors:  Michelle E Turvey; Manuela Klingler-Hoffmann; Peter Hoffmann; Shaun R McColl
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

2.  p21-activated Kinases (PAKs) Mediate the Phosphorylation of PREX2 Protein to Initiate Feedback Inhibition of Rac1 GTPase.

Authors:  Douglas Barrows; Sarah M Schoenfeld; Cindy Hodakoski; Antonina Silkov; Barry Honig; Anthony Couvillon; Aliaksei Shymanets; Bernd Nürnberg; John M Asara; Ramon Parsons
Journal:  J Biol Chem       Date:  2015-10-05       Impact factor: 5.157

3.  Phosphoinositide 3-kinase γ deficiency attenuates kidney injury and fibrosis in angiotensin II-induced hypertension.

Authors:  Changlong An; Jia Wen; Zhaoyong Hu; William E Mitch; Yanlin Wang
Journal:  Nephrol Dial Transplant       Date:  2020-09-01       Impact factor: 5.992

Review 4.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

Authors:  Lauren M Thorpe; Haluk Yuzugullu; Jean J Zhao
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

Review 5.  Scaffolding Function of PI3Kgamma Emerges from Enzyme's Shadow.

Authors:  Maradumane L Mohan; Sathyamangla V Naga Prasad
Journal:  J Mol Biol       Date:  2017-02-06       Impact factor: 5.469

6.  PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors.

Authors:  Julia C F Quintanilha; Alessandro Racioppi; Jin Wang; Amy S Etheridge; Stefanie Denning; Carol E Peña; Andrew D Skol; Daniel J Crona; Danyu Lin; Federico Innocenti
Journal:  Pharmacogenomics J       Date:  2021-11-13       Impact factor: 3.245

7.  Gβγ is a direct regulator of endogenous p101/p110γ and p84/p110γ PI3Kγ complexes in mouse neutrophils.

Authors:  Natalie K Rynkiewicz; Karen E Anderson; Sabine Suire; Daniel M Collins; Eleftherios Karanasios; Oscar Vadas; Roger Williams; David Oxley; Jonathan Clark; Len R Stephens; Phillip T Hawkins
Journal:  Sci Signal       Date:  2020-11-03       Impact factor: 8.192

8.  Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity.

Authors:  Aliaksei Shymanets; Oscar Vadas; Cornelia Czupalla; Jaclyn LoPiccolo; Michael Brenowitz; Alessandra Ghigo; Emilio Hirsch; Eberhard Krause; Reinhard Wetzker; Roger L Williams; Christian Harteneck; Bernd Nürnberg
Journal:  Biochem J       Date:  2015-07-01       Impact factor: 3.857

Review 9.  The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors.

Authors:  Hazel A Rogers; Jasper Estranero; Keshni Gudka; Richard G Grundy
Journal:  Oncotarget       Date:  2017-01-10

10.  Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs).

Authors:  Oscar Vadas; Hashem A Dbouk; Aliaksei Shymanets; Olga Perisic; John E Burke; Widian F Abi Saab; Bassem D Khalil; Christian Harteneck; Anne R Bresnick; Bernd Nürnberg; Jonathan M Backer; Roger L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.